Interpace Biosciences Inc (IDXG)
3.28
+0.29
(+9.70%)
USD |
OTCM |
Nov 13, 16:00
Interpace Biosciences Market Cap: 14.41M for Nov. 13, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 14.41M |
| November 12, 2024 | 13.14M |
| November 11, 2024 | 12.85M |
| November 08, 2024 | 14.37M |
| November 07, 2024 | 14.28M |
| November 06, 2024 | 12.72M |
| November 05, 2024 | 13.14M |
| November 04, 2024 | 10.72M |
| November 01, 2024 | 10.77M |
| October 31, 2024 | 10.77M |
| October 30, 2024 | 10.55M |
| October 29, 2024 | 11.43M |
| October 28, 2024 | 11.91M |
| October 25, 2024 | 11.95M |
| October 24, 2024 | 11.91M |
| October 23, 2024 | 12.52M |
| October 22, 2024 | 12.74M |
| October 21, 2024 | 11.87M |
| October 18, 2024 | 12.88M |
| October 17, 2024 | 13.18M |
| October 16, 2024 | 10.90M |
| October 15, 2024 | 8.876M |
| October 14, 2024 | 8.745M |
| October 11, 2024 | 8.811M |
| October 10, 2024 | 8.876M |
| Date | Value |
|---|---|
| October 09, 2024 | 9.008M |
| October 08, 2024 | 8.920M |
| October 07, 2024 | 8.811M |
| October 04, 2024 | 8.811M |
| October 03, 2024 | 8.789M |
| October 02, 2024 | 8.767M |
| October 01, 2024 | 9.052M |
| September 30, 2024 | 7.910M |
| September 27, 2024 | 7.389M |
| September 26, 2024 | 7.389M |
| September 25, 2024 | 7.389M |
| September 24, 2024 | 7.470M |
| September 23, 2024 | 7.470M |
| September 20, 2024 | 7.369M |
| September 19, 2024 | 7.128M |
| September 18, 2024 | 6.855M |
| September 17, 2024 | 6.943M |
| September 16, 2024 | 6.591M |
| September 13, 2024 | 6.504M |
| September 12, 2024 | 6.811M |
| September 11, 2024 | 6.460M |
| September 10, 2024 | 6.679M |
| September 09, 2024 | 7.185M |
| September 06, 2024 | 7.101M |
| September 05, 2024 | 6.384M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.816M
Minimum
Dec 27 2022
43.08M
Maximum
Jul 02 2021
15.92M
Average
12.81M
Median
Nov 10 2020
Market Cap Benchmarks
| Fonar Corp | 100.07M |
| XWELL Inc | 8.942M |
| ProPhase Labs Inc | 15.07M |
| Applied DNA Sciences Inc | 1.803M |
| Veracyte Inc | 2.996B |
Market Cap Related Metrics
| PS Ratio | 0.3457 |
| Price to Free Cash Flow | 5.788 |
| Price | 3.28 |
| Operating PE Ratio | 3.248 |